7 news items
AbbVie Appoints Roxanne S. Austin as Lead Independent Director of the Board of Directors
ABBV
20 Jun 24
, diverse and highly independent Board of Directors committed to the highest standards of corporate governance," said
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
ABBV
CYTO
ONCY
24 May 24
, ultimately offering clinicians a powerful tool to detect cancer across diverse omic layers." Altamira Therapeutics Ltd
The Analyst Verdict: AbbVie In The Eyes Of 5 Experts
ABBV
17 May 24
the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week®
ABBV
17 May 24
of IBD. Recognizing that every patient is different, AbbVie has taken bold steps to help shape the IBD landscape, building a diverse portfolio
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders
ABBV
13 May 24
are optimized for safety, efficacy, and patient access. Gilgamesh is advancing a diverse portfolio of programs, including two lead clinical programs
ugfr87wp
ABBV
ATNM
AZN
22 Apr 24
medications. Johnson & Johnson's (NYSE:JNJ) diverse portfolio, including
y525emvfxpw0346xv936u0fbckx87c79caqe710w8sq2iustc6dagu0w2qju
ABBV
22 Mar 24
(NYSE:ABBV), offering a diverse range of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings
- Prev
- 1
- Next